Search

everythinglearnresearchcommunity

for

Search:↓

Accurate diagnosis of cicatricial alopecias requires thorough scalp examination and multiple biopsy techniques.

Hair transplants can cause hair loss if done while lichen planopilaris is active; wait until it's inactive for two years and check with a scalp biopsy first.

Dermoscopy helps diagnose frontal fibrosing alopecia by identifying specific scalp features.

Frontal fibrosing alopecia is increasing, especially in postmenopausal women, and treatment with finasteride can improve it.

The conclusion is that having both Frontal Fibrosing Alopecia and Discoid Lupus Erythematosus may suggest a shared immune response in certain people, and a mix of antimalarial drugs and 5-alfa-reductase inhibitors is recommended for treatment.

LED therapy can safely and effectively regrow eyebrows in people with frontal fibrosing alopecia.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

Oral Minoxidil could be a safe and effective alternative treatment for various non-androgenic alopecias.

Botulinum Toxin Type A delivered through the skin may be a promising treatment for Frontal Fibrosing Alopecia.

Minoxidil is the only FDA-approved treatment for female hair loss, with other potential treatments needing more research for effectiveness.

The review suggests more research is needed to understand Frontal fibrosing alopecia, a condition causing hairline recession in postmenopausal women.

Female pattern hair loss is common and should be treated early to prevent worsening, with Minoxidil being the main approved treatment.

More research is needed to find effective treatments for Female Pattern Hair Loss.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Frontal fibrosing alopecia and androgenetic alopecia may be related, with a possible shared cause.

FAPD is a possible diagnosis for hair loss in patients of color and requires multiple evaluations for accurate diagnosis.

The study found that treatment improved hair condition in patients with Fibrosing Alopecia in a Pattern Distribution in Chile.

A woman's hair loss from graft versus host disease helps understand similar hair loss conditions.

Red dots on the upper chest may be an early sign of certain types of hair loss.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

The document concludes that treatment can improve hair growth and symptoms in Fibrosing Alopecia in a Pattern Distribution.

A simple scalp scraping can effectively distinguish fibrosing alopecia from androgenetic alopecia with seborrheic dermatitis.

Japanese cases of fibrosing alopecia show a unique age and hair loss pattern, possibly due to racial differences.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

The study suggests fibrosing alopecia in a pattern distribution has distinct features and may vary by race.

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.